| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.900 | limited | 0.865 | 0 | 0 | 2001 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 0.895 | 0 | 0 | 1992 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
disease | 0.700 | None | 0.750 | 0 | 0 | 1998 | 2019 | ||||||||
|
reticulon 4 receptor | 0.595 | 0.692 | 0.96 |
|
disease | 0.670 | None | 0.857 | 0 | 0 | 2004 | 2017 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.500 | None | 0.841 | 0 | 0 | 1992 | 2020 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2001 | 2010 | |||||||||
|
chitinase 3 like 1 | 0.419 | 0.885 | 1.1E-05 |
|
disease | 0.500 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
proline dehydrogenase 1 | 0.612 | 0.692 | 5.4E-12 |
|
disease | 0.500 | None | 0.955 | 0 | 0 | 2004 | 2018 | ||||||||
|
D-amino acid oxidase activator | 0.678 | 0.346 | 1.4E-04 |
|
disease | 0.500 | None | 0.965 | 0 | 0 | 2002 | 2018 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 0.887 | 0 | 0 | 1984 | 2020 | ||||||||
|
mediator complex subunit 12 | 0.476 | 0.769 | 1.00 |
|
disease | 0.490 | None | 0.800 | 0 | 0 | 2000 | 2010 | ||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.490 | None | 0.889 | 0 | 0 | 2000 | 2019 | |||||||||
|
ARVCF delta catenin family member | 0.540 | 0.769 | 5.0E-11 |
|
disease | 0.460 | None | 1.000 | 0 | 0 | 2005 | 2019 | ||||||||
|
ubiquitin recognition factor in ER associated degradation 1 | 0.537 | 0.769 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2001 | 2013 | ||||||||
|
ATP binding cassette subfamily A member 13 | 0.722 | 0.308 | 8.8E-114 |
|
disease | 0.420 | None | 1.000 | 0 | 1 | 2009 | 2017 | ||||||||
|
gap junction protein alpha 5 | 0.575 | 0.577 | 1.8E-02 |
|
disease | 0.410 | None | < 0.001 | 0 | 0 | 2007 | 2007 | ||||||||
|
leucine rich repeat kinase 2 | 0.510 | 0.808 | 2.6E-30 |
|
disease | 0.410 | None | < 0.001 | 0 | 0 | 2014 | 2014 | ||||||||
|
gap junction protein alpha 8 | 0.587 | 0.577 | 2.2E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
apolipoprotein L2 | 0.722 | 0.308 | 7.3E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
VPS35 retromer complex component | 0.656 | 0.500 | 0.97 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
apolipoprotein L4 | 0.839 | 0.231 | 1.1E-03 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
USH1 protein network component sans | 0.659 | 0.346 | 3.7E-05 |
|
disease | 0.160 | None | 1.000 | 0 | 0 | 1998 | 2018 | ||||||||
|
euchromatic histone lysine methyltransferase 1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.130 | None | 1.000 | 0 | 1 | 2013 | 2019 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2019 | ||||||||
|
calcium and integrin binding family member 2 | 0.545 | 0.808 | 1.4E-03 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2008 | 2008 |